Bringing More Value with Science

At ROMEG our goal is to provide plant originated solutions for every day ailments. We are patient and physician focused. Our mission is to address unmet or underserved medical needs with products that are targeted, patient-friendly and nature-originated. We are focused on building a product pipeline by redesigning currently FDA approved treatments to offer benefits to patients and physicians.

Our Team

Indu Muni, Ph.D. Founder & CEO

Prior to starting ROMEG Therapeutics, Dr. Muni founded CutisPharma in 1998 and served as the Company’s CEO until May 2015. Dr. Muni brings over 40 years of experience in the pharmaceutical industry, with a deep background in pharmacy and toxicology.

Previously, Dr. Muni served as the CEO of DynaGen, Inc., a publicly-held biotechnology company. Prior to DynaGen, Dr. Muni served in numerous senior level positions in the pharmaceutical, chemical and toxicology testing industries including BioAssay Systems, Inc., Miles Laboratories, and JT Baker. Dr. Muni has a Ph.D. in Pharmaceutical Sciences from the University of Mississippi.

Gita Muni, M.S., M.T. Co-Founder & Executive Vice President

Prior to co-founding ROMEG Therapeutics, Gita Muni helped found CutisPharma in 1998 and served as V.P. of Administration until May 2015. Prior to Cutis Pharma, she worked at DynaGen, Inc. helping to monitor clinical trials at various locations.

Additionally, she worked at the local hospitals as a medical technologist, (M.T.) Gita Muni holds a M.S. in pharmaceutical sciences from Bombay University, India, and she is also a registered medical technologist, (A.S.C.P.).

Naomi Vishnupad, Ph.D. Chief Scientific Officer

Dr. Vishnupad is an entrepreneurial scientific business executive with over 15 years of experience in inventing novel products and bringing new product technologies to the prescription and life sciences market.

She has served as the COO at Imaginative Research Associates, a dermatological product development company, for 14 years. Previously, Dr. Vishnupad held positions at Wyeth Pharmaceuticals and Bristol-Myers Squibb. She received a Ph.D. in Immunology from MCP-Hahnemann/Drexel University School of Medicine, a M.S. in Immunology from NYU, and a B.S. in Biology from Boston University.

Peter Mione, M.S. Consultant, Product Launch Support

Mr. Mione brings more than 35 years of experience in the pharmaceutical and medical device industries to ROMEG Therapeutics. In prior employment, Mr. Mione was responsible for ensuring that the documents, processes, and procedures necessary for the manufacturing and quality of the operations necessary for commercializing the products met the highest regulatory standard. He has developed and managed Quality Agreements to ensure oversight and control over the manufacture of products with principal contract manufacturers. Additionally, he has been responsible for maintenance of all federal, state, and local registrations and licensing, including FDA establishment and product registration for the handling, manufacture, storage, and distribution of products. Prior to consulting for ROMEG, Mr. Mione held senior regulatory positions at CutisPharma, Able Laboratories, and DynaGen, Inc. as well as regulatory affairs/quality assurance positions at Bioassay Systems, Inc. Mr. Mione has an M.S. in Pharmacology from Northeastern University.

James NagleConsultant, Commercial Operations and Logistics

With a 30-year history of demonstrable success in the Pharmaceutical and Distribution arena, Mr. Nagle is well suited to help tailor sales, marketing and operational strategies designed to leverage a company’s core competencies and intelligently capitalize on new business growth and market expansion opportunities. Prior to working with ROMEG Mr. Nagle was Senior Vice President of Commercial Operations at CutisPharma, his team successfully launched numerous Branded Pharmaceutical products during his tenure. Earlier in his career he was Vice President General Manager for AmeriSourceBergen Distribution Centers. Mr. Nagle has a B.S. in Economics and Finance from Bentley University.